Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-05-11

Clinical Trial Update: Sugammadex Versus Neostigmine for Reversal of Neuromuscular Blockade at the End of Kidney Transplantation Surgery [Phase 4]

View source ↗

Summary

A Phase 4 trial comparing sugammadex with neostigmine for reversal of neuromuscular blockade at the end of kidney transplantation surgery has completed, with re…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Neostigmine (neostigmine)
  • Sugammadex (sugammadex)

Snippet

Sponsor: University of Colorado, Denver | Conditions: Kidney Transplant; Complications, Postoperative Residual Curarization | Phase 4 | Status: COMPLETED | Results posted: 2025-05-11